Skip to main content
. 2023 May 11;14:1174138. doi: 10.3389/fimmu.2023.1174138

Figure 3.

Figure 3

Signaling lymphocytic activation molecule family receptor (SLAMF) 3 signal transduction in multiple myeloma (MM) cells. In MM, homotypic interactions between SLAMF3 molecules are established, stimulating the ERK signaling pathway and specific transcription factors (TFs). This pathway eventually causes survival, proliferation, migration, differentiation, and anti-apoptotic responses in MM cells, which facilitates the progression of the malignancy. Anti-SLAMF3 antibodies might restrict the development of malignancy.